GENERATE BIOMEDICINES INC (GENB) Stock Price & Overview
NASDAQ:GENB • US3709201004
Current stock price
The current stock price of GENB is 12.1 USD. Today GENB is down by -12%. In the past month the price increased by 7.94%.
GENB Key Statistics
- Market Cap
- 1.542B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
GENB Stock Performance
GENB Stock Chart
GENB Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to GENB.
GENB Earnings
GENB Forecast & Estimates
GENB Groups
Sector & Classification
GENB Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GENB Ownership
GENB Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.93 | 369.265B | ||
| AMGN | AMGEN INC | 15.01 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.85 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.4 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.32 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 44.27 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 10.72 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.74 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.39 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GENB
Company Profile
Generate Biomedicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Somerville, Massachusetts and currently employs 312 full-time employees. The company went IPO on 2026-02-27. Generate Biomedicines Inc is a United States-based biotechnology company. The firm uses machine learning (ML) and generative artificial intelligence (AI) to create novel, protein-based therapeutic candidates on demand. Its platform designs, simulates, and optimizes custom proteins such as antibodies, enzymes, and peptides to target specific diseases. The company also focuses on creating faster and better-targeted treatments for various diseases, including oncology, immunology and infectious diseases.
Company Info
IPO: 2026-02-27
GENERATE BIOMEDICINES INC
101 South Street, Suite 900
Somerville MASSACHUSETTS US
Employees: 312
Phone: 13026587581
GENERATE BIOMEDICINES INC / GENB FAQ
Can you describe the business of GENERATE BIOMEDICINES INC?
Generate Biomedicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Somerville, Massachusetts and currently employs 312 full-time employees. The company went IPO on 2026-02-27. Generate Biomedicines Inc is a United States-based biotechnology company. The firm uses machine learning (ML) and generative artificial intelligence (AI) to create novel, protein-based therapeutic candidates on demand. Its platform designs, simulates, and optimizes custom proteins such as antibodies, enzymes, and peptides to target specific diseases. The company also focuses on creating faster and better-targeted treatments for various diseases, including oncology, immunology and infectious diseases.
What is the current price of GENB stock?
The current stock price of GENB is 12.1 USD. The price decreased by -12% in the last trading session.
Does GENB stock pay dividends?
GENB does not pay a dividend.
How is the ChartMill rating for GENERATE BIOMEDICINES INC?
GENB has a ChartMill Technical rating of 4 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Can you provide the ownership details for GENB stock?
You can find the ownership structure of GENERATE BIOMEDICINES INC (GENB) on the Ownership tab.